Overview of SGA & Co. Ltd

These companies were all established in 2023 Swiss Global Agriculture Limited (SGA) was the first to be formed    in Uganda. As a startup company, in the global market, SGA focuses on the cultivation, processing, and export of high-quality cannabis adhering to stringent international standards. Seizing this opportunity, the company decided to establish a presence in both Switzerland and Uganda, where conditions were favorable for the cultivation of medical-grade cannabis. The strategic expansion into Uganda provided access to ideal climatic conditions for cultivating high-quality cannabis grown mostly by multipreneurs with profound backgrounds in finances and long-term experience in entrepreneurship making it a perfect fit for the company’s vision.

Thanks to the strategic financial backing of Swiss investors, SGA& Co Ltd has successfully expanded its operations and established cutting-edge cultivation facilities in Uganda. This vital support has enabled SGA& Co. Ltd to develop state-of-the-art infrastructure and implement rigorous quality control measures, ensuring strict compliance with both Swiss and international standards for medical cannabis production.

However, the post-COVID landscape has significantly impacted the cost of electricity, creating challenges for competitiveness within the CBD market. Many companies have been forced to relocate their production overseas or have faced bankruptcy due to the rising operational costs. In this challenging environment, only a select few industry leaders have managed to endure, underscoring the resilience and adaptability required to thrive in today’s market.

By leveraging our strategic advantages and the unwavering support of our investors, SGAL is positioned to navigate these complexities effectively. Our commitment to quality, innovation, and compliance not only sets us apart but also reinforces our dedication to maintaining a sustainable and competitive edge in the medical cannabis sector. The supportive legal environment in Switzerland, coupled with financial aid from Swiss investors, has been instrumental in SGAL’s success. This regulatory stability has not only enabled the company to cultivate and process cannabis for medical purposes but has also facilitated international collaboration. SGAL extends its gratitude to its Swiss investors for their confidence and support, which have been crucial in enabling the company to thrive across both continents.

Swiss Global Agriculture is primarily focused on the cultivation and advancement of medical cannabis (also known as medicinal cannabis) and the production of cannabis-based products, alongside the growth of industrial-grade sativa for various applications. In Uganda, the company aims to utilize cannabis’s therapeutic properties to support individuals managing various health conditions by leveraging the plant’s active cannabinoids.

The cannabis plant has a long history of medicinal use across different cultures worldwide. Swiss Global Agriculture Limited is committed to integrating the East African region into the expanding global hemp and cannabis market, contributing to a sector that is experiencing significant growth in more developed markets.